NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2014 | $109,000 | +18.5% | 3,050 | -14.2% | 0.00% | 0.0% |
Q3 2014 | $92,000 | -22.0% | 3,556 | 0.0% | 0.00% | 0.0% |
Q2 2014 | $118,000 | +1.7% | 3,556 | -8.5% | 0.00% | 0.0% |
Q1 2014 | $116,000 | +0.9% | 3,885 | +2.6% | 0.00% | 0.0% |
Q4 2013 | $115,000 | -70.6% | 3,785 | -69.2% | 0.00% | -66.7% |
Q3 2013 | $391,000 | +279.6% | 12,294 | +79.9% | 0.00% | +200.0% |
Q2 2013 | $103,000 | – | 6,832 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARVEY CAPITAL MANAGEMENT INC | 549,425 | $16,680,000 | 6.89% |
Opaleye Management Inc. | 205,000 | $5,945,000,000 | 4.67% |
Rhenman & Partners Asset Management AB | 240,000 | $7,286,000 | 2.85% |
SECTORAL ASSET MANAGEMENT INC | 1,774,919 | $53,887,000 | 2.32% |
Eventide Asset Management | 242,700 | $7,368,000 | 2.27% |
OAK RIDGE INVESTMENTS LLC | 2,713,717 | $82,389,000 | 2.16% |
First Light Asset Management, LLC | 68,245 | $2,072,000 | 1.76% |
Broadfin Capital, LLC | 400,000 | $12,144,000 | 1.60% |
Cupps Capital Management, LLC | 748,175 | $22,714,000 | 1.54% |
FCG ADVISORS, LLC | 70,651 | $2,145,000 | 1.45% |